Literature DB >> 2415353

Antibodies to the autophosphorylation sites of the epidermal growth factor receptor protein-tyrosine kinase as probes of structure and function.

W J Gullick, J Downward, M D Waterfield.   

Abstract

Antisera were prepared against three synthetic peptides with amino acid sequences identical to those surrounding the three major autophosphorylation sites of the epidermal growth factor (EGF) receptor. The affinity-purified antibodies reacted strongly in an enzyme-linked immunosorbent assay against the immunizing peptide but showed little cross-reaction with the other two phosphorylation site peptides. EGF receptors labelled by autophosphorylation could be specifically precipitated by each of the phosphorylation site antibodies. The antibodies recognised EGF receptors labelled at each of the autophosphorylation sites, indicating that they could bind to the immunizing sequences irrespective of their states of phosphorylation. The antibodies were able to inhibit EGF receptor autophosphorylation without affecting EGF-stimulated tyrosine kinase activity towards exogenous peptide substrates, suggesting that the kinase and autophosphorylation sites were in distinct domains. Immunofluorescent staining of A431 cells showed that the autophosphorylation site sequences resided inside the cell. The autophosphorylation sites were shown to be within a domain of 20 000 mol. wt. which could be cleaved from the receptor through limited proteolysis by the calcium-dependent protease, calpain. The position of cleavage of the EGF receptor by the protease was mapped to lie between residues 996 and 1059. These results are discussed in the context of a model for the structure and function of the human EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415353      PMCID: PMC554591          DOI: 10.1002/j.1460-2075.1985.tb04016.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Rapid isolation of plasma membranes in high yield from cultured fibroblasts.

Authors:  D Thom; A J Powell; C W Lloyd; D A Rees
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

Review 2.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins.

Authors:  J A Cooper; D F Bowen-Pope; E Raines; R Ross; T Hunter
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

Review 4.  Epidermal growth factor receptors.

Authors:  E D Adamson; A R Rees
Journal:  Mol Cell Biochem       Date:  1981-02-11       Impact factor: 3.396

5.  Purification and characterization of a calcium-activated neutral protease from rabbit skeletal muscle which requires calcium ions of microM order concentration.

Authors:  M Inomata; M Hayashi; M Nakamura; K Imahori; S Kawashima
Journal:  J Biochem       Date:  1983-01       Impact factor: 3.387

6.  Antibodies of predetermined specificity detect two retroviral oncogene products and inhibit their kinase activities.

Authors:  S Sen; R A Houghten; C J Sherr; A Sen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Proteolytic cleavage of epidermal growth factor receptor. A Ca2+-dependent, sulfhydryl-sensitive proteolytic system in A431 cells.

Authors:  D Cassel; L Glaser
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

8.  A monoclonal antibody to the human epidermal growth factor receptor.

Authors:  M D Waterfield; E L Mayes; P Stroobant; P L Bennet; S Young; P N Goodfellow; G S Banting; B Ozanne
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

9.  The kinetics of tyrosine phosphorylation by the purified epidermal growth factor receptor kinase of A-431 cells.

Authors:  C Erneux; S Cohen; D L Garbers
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

10.  Phosphorylation of tyrosine-416 is not required for the transforming properties and kinase activity of pp60v-src.

Authors:  M A Snyder; J M Bishop; W W Colby; A D Levinson
Journal:  Cell       Date:  1983-03       Impact factor: 41.582

View more
  23 in total

1.  Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.

Authors:  R J Epstein; B J Druker; T M Roberts; C D Stiles
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 2.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

3.  Mutation of a protein kinase C phosphorylation site in the erbB protein of avian erythroblastosis virus.

Authors:  S J Decker; B Dorai; S Russell
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

4.  cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules.

Authors:  L Claesson-Welsh; A Eriksson; A Morén; L Severinsson; B Ek; A Ostman; C Betsholtz; C H Heldin
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

5.  The two major envelope proteins of equine arteritis virus associate into disulfide-linked heterodimers.

Authors:  A A de Vries; S M Post; M J Raamsman; M C Horzinek; P J Rottier
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Biosynthesis of glycoproteins E and I of feline herpesvirus: gE-gI interaction is required for intracellular transport.

Authors:  J D Mijnes; L M van der Horst; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer.

Authors:  W Bergler; H Bier; U Ganzer
Journal:  Arch Otorhinolaryngol       Date:  1989

8.  Cloning and characterization of a human type II receptor for bone morphogenetic proteins.

Authors:  B L Rosenzweig; T Imamura; T Okadome; G N Cox; H Yamashita; P ten Dijke; C H Heldin; K Miyazono
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells.

Authors:  U Chen; R H Scheuermann; T Wirth; T Gerster; R G Roeder; K Harshman; C Berger
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

10.  Structural proteins of equine arteritis virus.

Authors:  A A de Vries; E D Chirnside; M C Horzinek; P J Rottier
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.